Avantra Biosciences Changes Company Name to Courtagen Life Sciences, Inc.

WOBURN, Mass., Aug. 30, 2011 /PRNewswire via COMTEX/ -- Avantra Biosciences Corporation today announced that effective immediately it is changing its name to Courtagen Life Sciences, Inc. The company will continue to use the Avantra name for their proteomics portfolio, which includes the Avantra Biomarker System. The Avantra Biomarker System offers users rapid, easy-to-use, quantitative multiplex protein assays using catalog or custom reagents.

Brian McKernan, CEO of Courtagen Life Sciences explained, "The name change reflects the Company's new strategic focus on developing advanced technologies in both genomic and proteomic areas and our commitment to bring additional needed technologies to the market."

In addition to the name change, the company unveiled a new logo and website, www.courtagen.com .

About Courtagen Life Sciences:

Courtagen Life Sciences, Inc. ("CLS") provides innovative and disruptive proteomic and genomic products and services to the Life Sciences industry. Our companies deliver tools that enable researchers and clinicians to make better decisions regarding drug development and patient care.

Suggested Articles

Less than two years after taking the reins from founding chief Rusty Williams, Five Prime Therapeutics’ CEO Aron Knickerbocker is exiting the company.

A Roche compound that was designed to treat rheumatoid arthritis could improve the heart's ability to repair itself, a Vanderbilt team found.

After a whirlwind year and two quick-fire raises, cancer startup Black Diamond Therapeutics has nabbed Yumanity, Merck KGaA and SR One veterans to help head up…